BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10740410)

  • 1. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A; Szelachowska M; Kinalska I
    Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
    Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
    Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Williams AJ; Bingley PJ; Moore WP; Gale EA;
    Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M; Karjalainen J; Akerblom HK
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
    Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
    Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children.
    Adojaan B; Sabbah E; Vähäsalo P; Akerblom HK; Podar T; Knip M
    J Pediatr Endocrinol Metab; 1999; 12(5):667-72. PubMed ID: 10703539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
    Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
    Borg H; Fernlund P; Sundkvist G
    Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG
    Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.